AEON Eyeing FDA Meeting On Botox Biosimilar By The End Of 2025

California-Based Firm Has Begun Primary Analytical Studies For ABP-450 Candidate

 
• By Dean Rudge
  
Bottles of Botulinum Toxin or Botox were rowed in the Surgery clinic display for customer showing off. Bangkok, Thailand September 2, 2017
• Source: Shutterstock

More from Generics Bulletin

More from Products